US Dollar

Showing 11401 articles
Business

Arcellx Stock: A Tale of Two Valuations Amid Biotech Volatility

Arcellx (ACLX) shares are caught in a tug-of-war between conflicting valuation signals. While a sky-high price-to-book ratio suggests the stock is richly valued, a discounted cash flow model implies massive upside potential. We examine the data behind the biotech's recent price swings and what investors are really betting on.

Business

Newmark Group Secures Major Deals in PENN District and Multifamily Sector, Spotlight Returns to Valuation

Newmark Group is back in the headlines following two significant mandates: leading the retail transformation at Vornado's PENN District and arranging a $690 million refinancing for a large multifamily portfolio. This comes as the firm's strong long-term shareholder returns contrast with its modest year-to-date stock performance, raising questions about its current market valuation.